Holen Sie sich die Stockscreener-App
4.1301
4.30%
0.1701
Handel nachbörslich:
4.10
-0.0301
-0.73%
Schlusskurs vom Vortag:
$3.96
Offen:
$3.96
24-Stunden-Volumen:
280.73K
Relative Volume:
0.97
Marktkapitalisierung:
$2.10M
Einnahmen:
$4.70M
Nettoeinkommen (Verlust:
$-4.99M
KGV:
-0.6433
EPS:
-6.42
Netto-Cashflow:
$-5.29M
1W Leistung:
-8.63%
1M Leistung:
-21.93%
6M Leistung:
-59.51%
1J Leistung:
-78.66%
1-Tages-Spanne:
$3.91
$4.4899
1-Wochen-Bereich:
$3.84
$4.58
52-Wochen-Spanne:
$3.64
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
Firmenname
Salarius Pharmaceuticals Inc
Sektor
Branche
Telefon
346-772-0346
Adresse
2450 HOLCOMBE BLVD, HOUSTON
Vergleichen Sie SLRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
4.1301 | 3.74M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-04-27 | Eingeleitet | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc Aktie (SLRX) Neueste Nachrichten
Salarius Pharma Stock Jumps After-Hours As Nasdaq Compliance Clears Path For Decoy Merger — Retail Bulls Bet On Breakout - Stocktwits
Salarius Pharmaceuticals Regains Nasdaq Compliance - TradingView
Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
Will Salarius Pharmaceuticals Inc. stock benefit from green energy trendsWall Street Watch & Safe Swing Trade Setups - newser.com
How institutional ownership impacts Salarius Pharmaceuticals Inc. stockRate Hike & Weekly High Conviction Ideas - newser.com
Intraday pattern recognizer results for Salarius Pharmaceuticals Inc.July 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
How higher bond yields impact Salarius Pharmaceuticals Inc. (FP10) stockCPI Data & Weekly Setup with High ROI Potential - newser.com
How to recover losses in Salarius Pharmaceuticals Inc. stock2025 Price Momentum & Low Drawdown Investment Ideas - newser.com
Can machine learning forecast Salarius Pharmaceuticals Inc. recoveryPortfolio Update Report & Precise Buy Zone Identification - newser.com
Real time alert setup for Salarius Pharmaceuticals Inc. performanceRisk Management & Verified Technical Signals - newser.com
Salarius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements Ahead of Merger with Decoy Therapeutics - Quiver Quantitative
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements - GlobeNewswire
Can Salarius Pharmaceuticals Inc. stock deliver sustainable ROETrade Volume Report & Weekly Return Optimization Alerts - newser.com
Salarius Pharmaceuticals Inc. stock momentum explainedTrade Ideas & Expert Curated Trade Ideas - newser.com
Long term hold vs stop loss in Salarius Pharmaceuticals Inc.July 2025 Catalysts & Weekly Momentum Picks - newser.com
What data driven models say about Salarius Pharmaceuticals Inc.’s futureJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Is Salarius Pharmaceuticals Inc. (FP10) stock positioned for secular growth2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Why Salarius Pharmaceuticals Inc. (FP10) stock could break out in 2025Quarterly Market Review & Momentum Based Trading Signals - newser.com
Ewing Sarcoma Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featuring Leading Companies: Salarius Pharma - Barchart.com
Salarius Pharmaceuticals (NASDAQ:SLRX) Trading 1% Higher – Here’s Why - Defense World
Salarius Pharmaceuticals Awaits Nasdaq Compliance Confirmation - TipRanks
What Fibonacci levels say about Salarius Pharmaceuticals Inc. reboundQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Exit strategy if you’re trapped in Salarius Pharmaceuticals Inc.Market Movers & Daily Volume Surge Trade Alerts - newser.com
Risk vs reward if holding onto Salarius Pharmaceuticals Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com
Is Salarius Pharmaceuticals Inc. building a consolidation baseWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Should you wait for a breakout in Salarius Pharmaceuticals Inc.2025 Market Outlook & Safe Capital Growth Tips - newser.com
What momentum shifts mean for Salarius Pharmaceuticals Inc.2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com
Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):